id,exclusion,inclusion,name,therapeutic_area
ONCO-2024-001,"{'diagnosis_codes': ['C78', 'C79'], 'medical_history_codes': ['Z94', 'B20'], 'prohibited_medications': [{'name': 'warfarin', 'reason': 'Bleeding risk', 'washout_days': 7}, {'name': 'CYP3A4_inhibitors', 'reason': 'Drug interaction', 'washout_days': 14}]}","{'age': {'min_age': 18, 'max_age': 75, 'weight': 1.0}, 'diagnosis_codes': ['C50', 'Z85.3'], 'lab_requirements': {'ANC': {'min': 1500, 'max': None, 'unit': 'cells/uL'}, 'platelets': {'min': 100000, 'max': None, 'unit': 'cells/uL'}, 'creatinine': {'min': None, 'max': 1.5, 'unit': 'mg/dL'}, 'bilirubin': {'min': None, 'max': 1.5, 'unit': 'mg/dL'}, 'ALT': {'min': None, 'max': 80, 'unit': 'U/L'}, 'AST': {'min': None, 'max': 80, 'unit': 'U/L'}}, 'ecog_performance': {'max': 1}}",Phase III Breast Cancer Study,oncology
CARDIO-2024-002,"{'diagnosis_codes': ['I21', 'I22'], 'medical_history_codes': ['Z95.1', 'Z95.2'], 'prohibited_medications': [{'name': 'amiodarone', 'reason': 'QT prolongation', 'washout_days': 30}, {'name': 'digoxin', 'reason': 'Toxicity risk', 'washout_days': 7}]}","{'age': {'min_age': 40, 'max_age': 85, 'weight': 1.0}, 'diagnosis_codes': ['I50'], 'lab_requirements': {'BNP': {'min': 100, 'max': None, 'unit': 'pg/mL'}, 'eGFR': {'min': 30, 'max': None, 'unit': 'mL/min'}, 'potassium': {'min': 3.5, 'max': 5.5, 'unit': 'mEq/L'}}, 'ejection_fraction': {'max': 40}}",Phase II Heart Failure Study,cardiovascular
default,"{'diagnosis_codes': [], 'medical_history_codes': ['Z94'], 'prohibited_medications': []}","{'age': {'min_age': 18, 'max_age': 65, 'weight': 1.0}, 'diagnosis_codes': [], 'lab_requirements': {'creatinine': {'min': None, 'max': 2.0, 'unit': 'mg/dL'}}}",Default Protocol Template,general
